Case Reports
doi: 10.3748/wjg.14.3085.
Is infliximab safe to use while breastfeeding?
Affiliations
- PMID: 18494064
- PMCID: PMC2712180
- DOI: 10.3748/wjg.14.3085
Item in Clipboard
Case Reports
Is infliximab safe to use while breastfeeding?
World J Gastroenterol.
.
Abstract
Inflammatory bowel disease (IBD) often affects women around the age of conception and pregnancy. Most drugs used to treat IBD are safe in pregnancy, but physicians must consider the clinical implications of certain treatment regimens in young, fertile females. We report an informative case of a pregnant patient with IBD who underwent treatment with infliximab during her pregnancy and while nursing her infant. Serum and breast milk infliximab levels were monitored throughout this time period. This case report suggests that targeted monoclonal antibodies and other biologic agents can be used with caution in pregnant and breastfeeding patients.
Similar articles
-
Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease.J Crohns Colitis. 2011 Dec;5(6):555-8. doi: 10.1016/j.crohns.2011.05.006. J Crohns Colitis. 2011. PMID: 22115374
-
Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn.Clin Gastroenterol Hepatol. 2006 Oct;4(10):1255-8. doi: 10.1016/j.cgh.2006.07.018. Clin Gastroenterol Hepatol. 2006. PMID: 17045211
-
Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception.Inflamm Bowel Dis. 2008 Mar;14(3):435-6. doi: 10.1002/ibd.20319. Inflamm Bowel Dis. 2008. PMID: 18050300 No abstract available.
-
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics.Am J Gastroenterol. 2011 Feb;106(2):214-23; quiz 224. doi: 10.1038/ajg.2010.464. Epub 2010 Dec 14. Am J Gastroenterol. 2011. PMID: 21157441 Review.
-
Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease.World J Gastroenterol. 2015 Dec 21;21(47):13205-11. doi: 10.3748/wjg.v21.i47.13205. World J Gastroenterol. 2015. PMID: 26715803 Free PMC article. Review.
Cited by
-
From conception to delivery: managing the pregnant inflammatory bowel disease patient.World J Gastroenterol. 2014 Apr 7;20(13):3495-506. doi: 10.3748/wjg.v20.i13.3495. World J Gastroenterol. 2014. PMID: 24707132 Free PMC article. Review.
-
Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.World J Gastroenterol. 2013 May 7;19(17):2591-602. doi: 10.3748/wjg.v19.i17.2591. World J Gastroenterol. 2013. PMID: 23674866 Free PMC article.
-
Management of Inflammatory Bowel Disease During Pregnancy.Dig Dis Sci. 2016 Aug;61(8):2194-2204. doi: 10.1007/s10620-016-4139-9. Epub 2016 Apr 11. Dig Dis Sci. 2016. PMID: 27068171 Review.
-
Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding Varies Widely: A Need for Further Education.Can J Gastroenterol Hepatol. 2016;2016:6193275. doi: 10.1155/2016/6193275. Epub 2016 Sep 20. Can J Gastroenterol Hepatol. 2016. PMID: 27725926 Free PMC article.
-
Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study.Ann Rheum Dis. 2017 Nov;76(11):1890-1896. doi: 10.1136/annrheumdis-2017-211384. Epub 2017 Aug 16. Ann Rheum Dis. 2017. PMID: 28814432 Free PMC article.
References
-
- Jospe ES, Peppercorn MA. Inflammatory bowel disease and pregnancy: a review. Dig Dis. 1999;17:201–207. - PubMed
-
- Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol. 2006;4:1255–1258. - PubMed
-
- Srinivasan R. Infliximab treatment and pregnancy outcome in active Crohn's disease. Am J Gastroenterol. 2001;96:2274–2275. - PubMed
-
- Remicade product information. In: Physicians desk reference. 58th ed. Montvale, NJ: Medical Economics Company, Inc; 2004. pp. 1145–1148.
-
- Reddy JG, Loftus EV Jr. Safety of infliximab and other biologic agents in the inflammatory bowel diseases. Gastroenterol Clin North Am. 2006;35:837–855. - PubMed
